4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Calcium Chelidonate: Semi-Synthesis, Crystallography, and Osteoinductive Activity In Vitro and In Vivo

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Calcium chelidonate [Ca(ChA)(H 2O) 3] n was obtained by semi-synthesis using natural chelidonic acid. The structure of the molecular complex was determined by X-ray diffraction analysis. The asymmetric unit of [Ca(ChA)(H 2O) 3] n includes chelidonic acid coordinated through three oxygen atoms, and three water ligands. The oxygen atoms of acid and oxygen atoms of water from each asymmetric unit are also coordinated to the calcium of another one, forming an infinite linear complex. Calcium geometry is close to the trigonal dodecahedron (D2d). The intra-complex hydrogen bonds additionally stabilize the linear species, which are parallel to the axis. In turn the linear species are packed into the 3D structure through mutual intercomplex hydrogen bonds. The osteogenic activity of the semi-synthetic CaChA was studied in vitro on 21-day hAMMSC culture and in vivo in mice using ectopic (subcutaneous) implantation of CaP-coated Ti plates saturated in vitro with syngeneic bone marrow. The enhanced extracellular matrix ECM mineralization in vitro and ectopic bone tissue formation in situ occurred while a water solution of calcium chelidonate at a dose of 10 mg/kg was used. The test substance promotes human adipose-derived multipotent mesenchymal stromal/stem cells (hAMMSCs), as well as mouse MSCs to differentiate into osteoblasts in vitro and in vivo, respectively. Calcium chelidonate is non-toxic and can stimulate osteoinductive processes.

          Related collections

          Most cited references55

          • Record: found
          • Abstract: found
          • Article: not found

          Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

          The considerable therapeutic potential of human multipotent mesenchymal stromal cells (MSC) has generated markedly increasing interest in a wide variety of biomedical disciplines. However, investigators report studies of MSC using different methods of isolation and expansion, and different approaches to characterizing the cells. Thus it is increasingly difficult to compare and contrast study outcomes, which hinders progress in the field. To begin to address this issue, the Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy proposes minimal criteria to define human MSC. First, MSC must be plastic-adherent when maintained in standard culture conditions. Second, MSC must express CD105, CD73 and CD90, and lack expression of CD45, CD34, CD14 or CD11b, CD79alpha or CD19 and HLA-DR surface molecules. Third, MSC must differentiate to osteoblasts, adipocytes and chondroblasts in vitro. While these criteria will probably require modification as new knowledge unfolds, we believe this minimal set of standard criteria will foster a more uniform characterization of MSC and facilitate the exchange of data among investigators.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Multilineage cells from human adipose tissue: implications for cell-based therapies.

            Future cell-based therapies such as tissue engineering will benefit from a source of autologous pluripotent stem cells. For mesodermal tissue engineering, one such source of cells is the bone marrow stroma. The bone marrow compartment contains several cell populations, including mesenchymal stem cells (MSCs) that are capable of differentiating into adipogenic, osteogenic, chondrogenic, and myogenic cells. However, autologous bone marrow procurement has potential limitations. An alternate source of autologous adult stem cells that is obtainable in large quantities, under local anesthesia, with minimal discomfort would be advantageous. In this study, we determined if a population of stem cells could be isolated from human adipose tissue. Human adipose tissue, obtained by suction-assisted lipectomy (i.e., liposuction), was processed to obtain a fibroblast-like population of cells or a processed lipoaspirate (PLA). These PLA cells can be maintained in vitro for extended periods with stable population doubling and low levels of senescence. Immunofluorescence and flow cytometry show that the majority of PLA cells are of mesodermal or mesenchymal origin with low levels of contaminating pericytes, endothelial cells, and smooth muscle cells. Finally, PLA cells differentiate in vitro into adipogenic, chondrogenic, myogenic, and osteogenic cells in the presence of lineage-specific induction factors. In conclusion, the data support the hypothesis that a human lipoaspirate contains multipotent cells and may represent an alternative stem cell source to bone marrow-derived MSCs.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Osteoinduction, osteoconduction and osseointegration.

              Osteoinduction is the process by which osteogenesis is induced. It is a phenomenon regularly seen in any type of bone healing process. Osteoinduction implies the recruitment of immature cells and the stimulation of these cells to develop into preosteoblasts. In a bone healing situation such as a fracture, the majority of bone healing is dependent on osteoinduction. Osteoconduction means that bone grows on a surface. This phenomenon is regularly seen in the case of bone implants. Implant materials of low biocompatibility such as copper, silver and bone cement shows little or no osteoconduction. Osseointegration is the stable anchorage of an implant achieved by direct bone-to-implant contact. In craniofacial implantology, this mode of anchorage is the only one for which high success rates have been reported. Osseointegration is possible in other parts of the body, but its importance for the anchorage of major arthroplasties is under debate. Ingrowth of bone in a porous-coated prosthesis may or may not represent osseointegration.
                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                Pharmaceuticals (Basel)
                Pharmaceuticals (Basel)
                pharmaceuticals
                Pharmaceuticals
                MDPI
                1424-8247
                17 June 2021
                June 2021
                : 14
                : 6
                : 579
                Affiliations
                [1 ]Department of Pharmaceutical Analysis, Siberian State Medical University, 634050 Tomsk, Russia; rybalova@ 123456nioch.nsc.ru
                [2 ]Department of Morphology and General Pathology, Siberian State Medical University, 634050 Tomsk, Russia; porohova_e@ 123456mail.ru (E.P.); khlusov63@ 123456mail.ru (I.K.); staranie@ 123456mail.ru (I.S.)
                [3 ]Research School of Chemistry & Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia
                [4 ]Center of Spectral Investigations, Novosibirsk Institute of Organic Chemistry, Siberian Branch, 630090 Novosibirsk, Russia; mvb63@ 123456mail.ru
                [5 ]Laboratory of Medicinal Chemistry, Novosibirsk Institute of Organic Chemistry, Siberian Branch, 630090 Novosibirsk, Russia; schultz@ 123456nioch.nsc.ru
                [6 ]Center for Immunology and Cell Biotechnology, Immanuel Kant Baltic Federal University, 236041 Kaliningrad, Russia; larisalitvinova@ 123456yandex.ru (L.L.); vshupletsova@ 123456mail.ru (V.S.); hazik36@ 123456mail.ru (O.K.)
                Author notes
                [* ]Correspondence: elenaavdeev@ 123456yandex.ru ; Tel.: +7-983-344-7381
                Author information
                https://orcid.org/0000-0001-7061-9843
                https://orcid.org/0000-0002-7317-2036
                https://orcid.org/0000-0003-3465-8452
                https://orcid.org/0000-0003-2398-5271
                https://orcid.org/0000-0002-0761-9696
                https://orcid.org/0000-0001-5231-6910
                Article
                pharmaceuticals-14-00579
                10.3390/ph14060579
                8235635
                3ac58b96-b819-4037-9fbc-4f4feabb1721
                © 2021 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( https://creativecommons.org/licenses/by/4.0/).

                History
                : 24 May 2021
                : 14 June 2021
                Categories
                Article

                calcium chelidonate,semi-synthesis,x-ray diffraction analysis,osteogenic activity

                Comments

                Comment on this article